tiprankstipranks
Advertisement
Advertisement

NeuroOne Regains Nasdaq Compliance After Bid Price Recovery

Story Highlights
  • NeuroOne fell out of Nasdaq bid price compliance after its stock traded below $1.00.
  • By April 30, 2026, NeuroOne regained Nasdaq compliance, easing listing and investor concerns.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
NeuroOne Regains Nasdaq Compliance After Bid Price Recovery

Claim 55% Off TipRanks

NeuroOne Medical Technologies ( (NMTC) ) just unveiled an announcement.

NeuroOne Medical Technologies disclosed that on May 6, 2025, it received a notice from Nasdaq indicating its common stock had closed below $1.00 per share for 30 consecutive business days, putting the company out of compliance with the exchange’s minimum bid price rule. On April 30, 2026, the company was informed by Nasdaq that it had regained compliance after its stock closed at or above $1.00 for 10 consecutive business days, resolving the deficiency and closing the matter, which removes an overhang on its listing status and may stabilize investor confidence.

The most recent analyst rating on (NMTC) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on NeuroOne Medical Technologies stock, see the NMTC Stock Forecast page.

Spark’s Take on NMTC Stock

According to Spark, TipRanks’ AI Analyst, NMTC is a Neutral.

The score is primarily weighed down by persistent losses and significant negative free cash flow despite improved gross margins and low leverage. Technicals are mixed but trend weak given the stock is below major moving averages. Valuation support is limited due to negative earnings and no dividend. Earnings-call guidance and product/program progress provide some offset, but liquidity/runway concerns cap upside.

To see Spark’s full report on NMTC stock, click here.

More about NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation operates in the medical technology sector, focusing on developing and commercializing advanced neurostimulation and monitoring solutions. The company’s shares are listed on the Nasdaq Capital Market, where it must comply with listing standards, including minimum bid price requirements that affect its trading status and investor accessibility.

Average Trading Volume: 39,674

Technical Sentiment Signal: Strong Sell

Current Market Cap: $36.75M

For a thorough assessment of NMTC stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1